Finance

Lists
Why is JANX down 5,34%?
Dive Deeper
JANX:NASDAQ
Janux Therapeutics Inc
17,18 $
-5,34%
(-0,97) 1D
17,18 $
0,00% (0,00)
After hours
Closed: 13 հոկ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JANX...
Open
18,06 $
High
18,14 $
Low
16,97 $
Mkt. cap
1,05 մլրդ
Avg. vol.
978,13 հզր
Volume
794,90 հզր
52-wk high
35,25 $
52-wk low
12,12 $
EPS
-1,64 $
Beta
2,40
Shares outstanding
61,14 մլն
No. of employees
113
Open
18,06 $
High
18,14 $
Low
16,97 $
Mkt. cap
1,05 մլրդ
Avg. vol.
978,13 հզր
Volume
794,90 հզր
52-wk high
35,25 $
52-wk low
12,12 $
EPS
-1,64 $
Beta
2,40
Shares outstanding
61,14 մլն
No. of employees
113
News stories
From web sources and news partners
About Janux Therapeutics Inc
CEO-
Employees113
Founded2017
Headquarters-
Sector-
Analyst ratings
Based on 11 analysts giving stock ratings to JANX in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
1
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for JANX in the last 3 months.
Highest
Current 17,18 $
60,00 $ (+249,24%)
Average
34,22 $ (+99,19%)
Lowest
14,00 $ (-18,51%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
45,00 $
+161,9%
10/01/2026
Kalpit Patel
Wolfe Research
Buy
Upgraded
23,00 $
+33,9%
08/24/2026
Matt Phipps
William Blair
Buy
Maintained
-
-
08/13/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
35,00 $
+103,7%
08/11/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
60,00 $
+249,2%
08/07/2026
Supawat Thongthip
Truist Financial
Buy
Maintained
-
-
08/07/2026
Kelsey Goodwin
Piper Sandler
Buy
Maintained
26,00 $
+51,3%
08/07/2026
Boris Peaker
JonesTrading
Buy
Maintained
28,00 $
+63%
08/07/2026
Bradley Canino
Guggenheim
Buy
Reiterated
55,00 $
+220,1%
08/06/2026
Alec Stranahan
Bank of America Securities
Buy
Reiterated
22,00 $
+28,1%
08/07/2026
Etzer Darout
Barclays
Sell
Maintained
14,00 $
-18,5%
08/07/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
22,00 $
+28,1%
05/11/2026
Robert Driscoll
Wedbush
Buy
Reiterated
36,00 $
+109,5%
05/08/2026
Marc Frahm
TD Cowen
Buy
Maintained
-
-
05/08/2026
Unknown Analyst
Wedbush
Buy
Reiterated
36,00 $
+109,5%
05/08/2026
David Dai
UBS
Hold
Downgraded
15,00 $
-12,7%
04/15/2026
Soumit Roy
JonesTrading
Buy
Maintained
50,00 $
+191%
04/06/2026
Karina Rabayeva
Truist Financial
Buy
Reiterated
80,00 $
+365,7%
03/03/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Reiterated
100,00 $
+482,1%
02/26/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
10,00 մլն
-
3,73 մլն
10,27 մլն
Cost of goods sold
34,63 մլն
31,55 մլն
26,81 մլն
30,99 մլն
Cost of revenue
34,63 մլն
31,55 մլն
26,81 մլն
30,99 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,62 մլն
10,85 մլն
11,13 մլն
10,96 մլն
Operating expense
10,62 մլն
10,85 մլն
11,13 մլն
10,96 մլն
Total operating expenses
45,25 մլն
42,40 մլն
37,95 մլն
41,96 մլն
Operating income
-35,25 մլն
-42,40 մլն
-34,21 մլն
-31,69 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-24,31 մլն
-31,95 մլն
-24,36 մլն
-21,97 մլն
EBT excluding unusual items
-24,31 մլն
-31,95 մլն
-24,36 մլն
-21,97 մլն
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-24,31 մլն
-31,95 մլն
-24,36 մլն
-21,97 մլն
Net profit margin
-243,13%
-
-652,59%
-214,01%
Earnings per share
-0,39
-0,51
-0,39
-0,35
Interest and investment income
10,94 մլն
10,46 մլն
9,85 մլն
9,72 մլն
Interest expense
-
-
-
-
Net interest expenses
10,94 մլն
10,46 մլն
9,85 մլն
9,72 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-34,75 մլն
-41,93 մլն
-33,74 մլն
-31,23 մլն
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google Apps